Stomatologiia, 2004, Vol.83(5), pp.20-3
Clinical and immunological efficiency of leukinferone in combination with polyoxidonium (immunomodulator) was studied in patients with relapsing herpetic stomatitis (RHS). The levels of alpha- and gamma-IFN were decreased, levels of IgM, IgG, and IgE were increased, active oxygen forms were actively produced, and the count of CD8(+)-cells was increased in patients with RHS. Treatment with polyoxidonium and leukinferone led to an increase of the blood levels of alpha- and gamma-IFN, decrease of IgM, IgG, and IgE levels, normalization of phagocytosis, and decrease of CD8(+)-cell count. The treatment had a pronounced clinical effect in patients with RHS of any severity, which indicates the efficiency of these drugs in combined therapy of patients with RHS.
Adjuvants, Immunologic -- Therapeutic Use ; Cytokines -- Therapeutic Use ; Interferon Type I -- Therapeutic Use ; Stomatitis, Herpetic -- Drug Therapy
MEDLINE/PubMed (U.S. National Library of Medicine)
View this record in MEDLINE/PubMed